Cargando…
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective
The COVID-19 outbreak has drastically changed practices inside hospitals, which include oncology routines. In oncology, malnutrition was and certainly still is a frequent problem associated with an increase in treatment-related toxicity, a reduced response to cancer treatment, an impaired quality of...
Autores principales: | Lobascio, Federica, Caccialanza, Riccardo, Monaco, Teresa, Cereda, Emanuele, Secondino, Simona, Masi, Sara, Crotti, Silvia, Rizzo, Gianpiero, Cappello, Silvia, Borioli, Valeria, Inglardi, Marco, Grugnetti, Giuseppina, Muzzi, Alba, Triarico, Antonio, Pedrazzoli, Paolo, Brugnatelli, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269683/ https://www.ncbi.nlm.nih.gov/pubmed/32495030 http://dx.doi.org/10.1007/s00520-020-05557-z |
Ejemplares similares
-
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy
por: Cereda, Emanuele, et al.
Publicado: (2019) -
Re. “Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol.” Author response
por: Caccialanza, Riccardo, et al.
Publicado: (2021) -
Reply to “Nutritional approach to patients with coronavirus: our experience in 914 COVID-19–bed hospital”
por: Caccialanza, Riccardo, et al.
Publicado: (2021) -
Muscle weakness as an additional criterion for grading sarcopenia‐related prognosis in patients with cancer
por: Cereda, Emanuele, et al.
Publicado: (2021) -
Early intravenous administration of nutritional support (IVANS) in
metastatic gastric cancer patients at nutritional risk, undergoing first-line
chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical
trial
por: Caccialanza, Riccardo, et al.
Publicado: (2020)